Hercules, CA — October 22, 2013 — More accurate and precise assessment of copy number variation (CNV), the number of copies of a particular gene present in a genome, may lead to improved diagnosis and therapy for cancer and other diseases, including autoimmune disorders. However, current technologies to determine copy number can be inaccurate, labor intensive, or prohibitively costly, diminishing their effectiveness in clinical applications.
Using Bio-Rad Laboratories’ Droplet Digital PCR (ddPCR™) technology, researchers can rapidly, accurately, and economically determine copy number states.Researchers from promininent universities throughout the US will present promising new research results using ddPCR at this year’s annual meeting of the American Society of Human Genetics (ASHG), held in Boston October 22–25, 2013.
“Since its introduction in 2011, Bio-Rad Laboratory's ddPCR technology has demonstrated the potential to be a transformative technology, based on its greater precision, reproducibility, and sensitivity than conventional approaches such as real-time PCR,” said George Karlin-Neumann, the scientific affairs director at Bio-Rad's Digital Biology Center.
Less than two years since Bio-Rad brought digital PCR systems to the market, studies using ddPCR assays have resulted in nearly 50 peer-reviewed publications.
Bio-Rad’s ddPCR technology will be showcased in 11 other presentations. For more information, visit Bio-Rad’s booth at ASHG (booth #839). Bio-Rad will also be hosting an ASHG lunch workshop on Thursday, October 24 at 12:30 PM in room 211 as well as a hospitality suite on Thursday, October 24 at 7:45 PM at the New England Aquarium, 1 Central Wharf in Boston. Please visit booth #839 for further details.
To register for Bio-Rad's six-part webinar series on Droplet Digital PCR or to view the list of Droplet Digital PCR system publications, visit http://www.bio-rad.com/ddPCR-Webinars. To learn more about ddPCR, please visit www.bio-rad.com/QX200.
About Bio-Rad
Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) has been at the center of scientific discovery for 60 years, manufacturing and distributing a broad range of products for life science research and clinical diagnostic markets. The company is renowned for its commitment to quality and customer service among university and research institutions, hospitals, public health and commercial laboratories, as well as the biotechnology, pharmaceutical, and food safety industries. Founded in 1952, Bio-Rad is based in Hercules, California, and serves more than 100,000 research and industry customers through its global network of operations. The company employs approximately 7,600 people worldwide and had revenues exceeding $2 billion in 2012. Visit us at www.bio-rad.com.
For more information contact:
Richard Kurtz
Bio-Rad Laboratories, Inc.
510-741-5638
richard_kurtz@bio-rad.com
Ken Li
Chempetitive Group
312-997-2436 x 112
kli@chempetitive.com